SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
ProMetic Life Sciences
An SI Board Since April 2016
Posts SubjectMarks Bans Symbol
250 11 0 PLI.TO
Emcee:  axial Type:  Moderated
Introduction Market Data Compact
 Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
25Analysis — [1] Echelon — 21 Oct/2016 [2] Canaccord — 20 Oct/2016 [3axial-10/22/2016
24GE HEALTHCARE BIO-SCIENCES AB v. PROMETIC LIFE SCIENCES INC. ET AL Patent 23943axial-10/21/2016
23MD comments on latest results — ' I have had a good look at the study resulaxial-10/21/2016
22PROMETIC’S PBI-4050 MEETS PRIMARY AND SECONDARY END POINTS IN METABOLIC SYNDROMEaxial110/20/2016
21Bloomberg TV — Prometic CEO: Looking for Partners for Alstrom Drug — Interviewaxial-10/12/2016
20Some more recent ProMetic Life Sciences Inc. analyst reports (Hat tip: stockmaxial-10/12/2016
19Comment from IR: "NASDAQ is most likely a 2017 event." Jim axial110/12/2016
18Analysis -- RBC: 12 Oct/2016 Positive Interim Results From PBI-4050 Ph. 2 Alstraxial-10/12/2016
17Analysis -- Panmure Gordon, 12 Oct/2016 : A significant milestone (Hat tip: beaxial110/12/2016
16Just listened to the CC regarding the early results for this Alstrom treatment. Cush-10/12/2016
15(2) ProMetic recommended by DSMB to continue Alstrom trial The Drug Safety Moniaxial-10/12/2016
14PROMETIC’S PBI-4050 SIGNIFICANTLY REDUCES LIVER FIBROSIS IN PATIENTS WITH ALSTR&axial-10/12/2016
13CIBC Analysis September 2016 ProMetic Life Sciences Inc. Setting The Stage Foraxial19/30/2016
12Bruce Campbell discusses Prometic Life Sciences Jimaxial-9/21/2016
11PROMETIC ANNOUNCES THE ADDITION OF TYMPANIC MEMBRANE PERFORATIONS (TMPs) TO ITS axial-9/6/2016
10PROMETIC ANNOUNCES AGREEMENT TO ACQUIRE TELESTA THERAPEUTICS INC. IN ALL SHARE Taxial-8/24/2016
9PROMETIC COMPLETES PATIENTS’ ENROLMENT IN PIVOTAL PLASMINOGEN PHASE 2/3 CLINICALaxial-8/11/2016
8PROMETIC COMPLETES ADULT PATIENTS’ ENROLMENT IN PIVOTAL IVIG PHASE 3 CLINICAL TRaxial-8/9/2016
7PROMETIC’S PLASMINOGEN GRANTED FAST TRACK DESIGNATION BY THE US FDA ProMetic Liaxial-6/13/2016
6Health Canada authorizes ProMetic to proceed with its PBI-4050 clinical trial inCush-5/18/2016
5LAVAL, QC , May 3, 2016 /CNW Telbec/ - ProMetic Life Sciences Inc. ( PLI.TO) ( PCush15/3/2016
4[Link] Explanation: NASH animal modelsaxial-4/14/2016
3PROMETIC CONFIRMS PBI-4050’S ANTI-FIBROTIC EFFECT IN NASH MODEL AND ON HUMAN HEPaxial-4/14/2016
2The Latest Hot Stocks In Short-Selling Circles Include Twitter, Prometic Life Anaxial-4/13/2016
1Equities Analysts Offer Predictions for ProMetic Life Sciences Inc.’s Q1 2016 Eaaxial-4/13/2016
 Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News